Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Overview of the treatment of testicular germ cell tumors

William K Oh, MD
Section Editor
Philip W Kantoff, MD
Deputy Editor
Michael E Ross, MD


Testicular cancers are among the most curable solid neoplasms. The five-year survival rate is over 95 percent, and approximately 400 deaths from testicular cancer are seen in the United States per year [1]. Initial therapy of early stage testicular germ cell tumors (GCTs) is based upon histology and tumor extent.

An overview of therapy for men with testicular GCTs is presented here. The clinical manifestations, diagnosis, and staging are presented separately, as are more detailed discussions of specific clinical scenarios.

(See "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors".)

(See "Treatment of stage I seminoma".)

(See "Treatment of stage II seminoma".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Sep 25, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.